Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Cortical Thickness and Serum NfL Explain Cognitive Dysfunction in Newly Diagnosed Patients With Multiple Sclerosis
Álvaro Javier Cruz-Gómez, Lucía Forero, Elena Lozano-Soto, et al.
Neurology Neuroimmunology & Neuroinflammation (2021) Vol. 8, Iss. 6
Open Access | Times Cited: 34

Showing 1-25 of 34 citing articles:

Causal relationship between multiple sclerosis and cortical structure: a Mendelian randomization study
Dongren Sun, Rui Wang, Qin Du, et al.
Journal of Translational Medicine (2024) Vol. 22, Iss. 1
Open Access | Times Cited: 13
Neurofilament light chain in blood as a diagnostic and predictive biomarker for multiple sclerosis: A systematic review and meta-analysis
Liangxia Ning, Bin Wang
PLoS ONE (2022) Vol. 17, Iss. 9, pp. e0274565-e0274565
Open Access | Times Cited: 35
Post-COVID cognitive deficits at one year are global and associated with elevated brain injury markers and grey matter volume reduction: national prospective study
Benedict Michael, Greta K. Wood, Brendan Sargent, et al.
Research Square (Research Square) (2024)
Open Access | Times Cited: 7
Predicting clinical progression and cognitive decline in patients with relapsing-remitting multiple sclerosis: a 6-year follow-up study
Karolina Kania, Mikołaj A. Pawlak, Maria Forycka, et al.
Neurologia i Neurochirurgia Polska (2024) Vol. 58, Iss. 2, pp. 176-184
Open Access | Times Cited: 7
Genetic influences on brain and cognitive health and their interactions with cardiovascular conditions and depression
Peter Zhukovsky, Earvin S. Tio, Gillian Coughlan, et al.
Nature Communications (2024) Vol. 15, Iss. 1
Open Access | Times Cited: 6
Cerebrospinal fluid biomarkers and cognitive functions at multiple sclerosis diagnosis
Eleonora Virgilio, Domizia Vecchio, Ilaria Crespi, et al.
Journal of Neurology (2022) Vol. 269, Iss. 6, pp. 3249-3257
Closed Access | Times Cited: 26
Emerging Biomarkers of Multiple Sclerosis in the Blood and the CSF: A Focus on Neurofilaments and Therapeutic Considerations
Tamás Biernacki, Zsófia Kokas, Dániel Sandi, et al.
International Journal of Molecular Sciences (2022) Vol. 23, Iss. 6, pp. 3383-3383
Open Access | Times Cited: 24
Molecular biomarkers and cognitive impairment in multiple sclerosis: State of the field, limitations, and future direction – A systematic review and meta-analysis
Tom-D. Rademacher, Sven G. Meuth, Heinz Wiendl, et al.
Neuroscience & Biobehavioral Reviews (2023) Vol. 146, pp. 105035-105035
Closed Access | Times Cited: 15
Novel serum biomarker associations with 7 Tesla MRI-defined cortical lesions, leptomeningeal enhancement, and deep gray matter volume in early multiple sclerosis
Andrei Miclea, Jonathan Zurawski, Brian C. Healy, et al.
Scientific Reports (2025) Vol. 15, Iss. 1
Open Access
Cognitive Impairment in Newly Diagnosed Patients with Multiple Sclerosis: A Systematic Review of Related Molecular Biomarkers and a Meta-Analysis of Associated Demographic and Disease-Related Characteristics
Konstantina Stavrogianni, Vasileios Giannopapas, Dimitrios K. Kitsos, et al.
Journal of Clinical Medicine (2025) Vol. 14, Iss. 8, pp. 2630-2630
Open Access
Glial fibrillary acidic protein as a biomarker in neuromyelitis optica spectrum disorder: a current review
Patrick Schindler, Orhan Aktaş, Marius Ringelstein, et al.
Expert Review of Clinical Immunology (2022) Vol. 19, Iss. 1, pp. 71-91
Closed Access | Times Cited: 22
Obesity causally influencing brain cortical structure: a Mendelian randomization study
Wenhui Chen, Jia Feng, Jie Guo, et al.
Cerebral Cortex (2023) Vol. 33, Iss. 15, pp. 9409-9416
Closed Access | Times Cited: 12
A multimodal marker for cognitive functioning in multiple sclerosis: the role of NfL, GFAP and conventional MRI in predicting cognitive functioning in a prospective clinical cohort
Maureen van Dam, Brigit A. de Jong, Eline A.J. Willemse, et al.
Journal of Neurology (2023) Vol. 270, Iss. 8, pp. 3851-3861
Open Access | Times Cited: 11
Human Umbilical Cord–Derived Mesenchymal Stem Cells in the Treatment of Multiple Sclerosis Patients: Phase I/II Dose-Finding Clinical Study
Fatima Jamali, Mayis Aldughmi, Serin Atiani, et al.
Cell Transplantation (2024) Vol. 33
Open Access | Times Cited: 4
Motor symptoms at onset and manual dexterity predict cognitive impairment in drug-naïve individuals with multiple sclerosis
Eman M. Khedr, M. M. A. Hassan, Mohamed Yosri Ezzeldeen, et al.
Journal of Neuroimmunology (2025) Vol. 401, pp. 578571-578571
Closed Access
Serum neurofilament light and MRI predictors of cognitive decline in patients with secondary progressive multiple sclerosis: Analysis from the MS-STAT randomised controlled trial
Thomas Williams, Carmen Tur, Arman Eshaghi, et al.
Multiple Sclerosis Journal (2022) Vol. 28, Iss. 12, pp. 1913-1926
Open Access | Times Cited: 18
Validity of serum neurofilament light chain as a prognostic biomarker of disease activity in multiple sclerosis
Monokesh Kumer Sen, Md Jakir Hossain, David A. Mahns, et al.
Journal of Neurology (2022) Vol. 270, Iss. 4, pp. 1908-1930
Closed Access | Times Cited: 18
High serum neurofilament light chain levels correlate with brain atrophy and physical disability in multiple sclerosis
Arabella Buchmann, Lukas Pirpamer, Daniela Pinter, et al.
European Journal of Neurology (2023) Vol. 30, Iss. 5, pp. 1389-1399
Open Access | Times Cited: 10
Neurofilaments – Small proteins of physiological significance and predictive power for future neurodegeneration and cognitive decline across the life span
Julia Elmers, Lorenza S. Colzato, Katja Akgün, et al.
Ageing Research Reviews (2023) Vol. 90, pp. 102037-102037
Closed Access | Times Cited: 10
Multiple sclerosis and circadian rhythms: Can diet act as a treatment?
Olga Pivovarova‐Ramich, Hanna Zimmermann, Friedemann Paul
Acta Physiologica (2023) Vol. 237, Iss. 4
Open Access | Times Cited: 8
The effects of cytomegalovirus on brain structure following sport-related concussion
Jonathan Savitz, Bryna D. Goeckner, Bart N. Ford, et al.
Brain (2023) Vol. 146, Iss. 10, pp. 4262-4273
Open Access | Times Cited: 8
Brain-derived neurotrophic factor and neurofilament light chain in cerebrospinal fluid are inversely correlated with cognition in Multiple Sclerosis at the time of diagnosis
Yavor Yalachkov, Victoria Anschütz, Jasmin Jakob, et al.
Multiple Sclerosis and Related Disorders (2022) Vol. 63, pp. 103822-103822
Closed Access | Times Cited: 13
Neurofilament Light Chain in Adult and Pediatric Multiple Sclerosis: A Promising Biomarker to Better Characterize Disease Activity and Personalize MS Treatment
Angelo Ghezzi, Rinze F. Neuteboom
Neurology and Therapy (2023) Vol. 12, Iss. 6, pp. 1867-1881
Open Access | Times Cited: 7
Classification of multiple sclerosis clinical profiles using machine learning and grey matter connectome
Berardino Barile, Pooya Ashtari, Claudio Stamile, et al.
Frontiers in Robotics and AI (2022) Vol. 9
Open Access | Times Cited: 11
Relationship between apathy and cognitive dysfunctions in multiple sclerosis: A 4-year prospective longitudinal study
Simona Raimo, Luigi Trojano, Mariachiara Gaita, et al.
Multiple Sclerosis and Related Disorders (2022) Vol. 63, pp. 103929-103929
Closed Access | Times Cited: 8
Page 1 - Next Page

Scroll to top